Confirmation of the Drug–drug Interaction Potential between Cobicistat-boosted Antiretroviral Regimens and Hormonal Contraceptives
Sign Up to like & getrecommendations! Published in 2020 at "Antiviral Therapy"
DOI: 10.3851/imp3343
Abstract: Background Cobicistat (COBI), a CYP3A inhibitor, is a pharmacokinetic enhancer that increases exposures of the HIV protease inhibitors (PIs) atazanavir (ATV) and darunavir (DRV). The potential drug interaction between COBI-boosted PIs and hormonal contraceptives, which… read more here.
Keywords: cobi; drug interaction; drospirenone; atv cobi ... See more keywords